1145 related articles for article (PubMed ID: 11654274)
1. Special informed consent requirements are included in protocol review procedures.
Maloney DM
Hum Res Rep; 1995 Jul; 10(7):1-2. PubMed ID: 11654274
[No Abstract] [Full Text] [Related]
2. NIH guidelines for research involving recombinant DNA molecules.
Wilson DJ
Account Res; 1993; 3(2-3):177-85. PubMed ID: 11652293
[No Abstract] [Full Text] [Related]
3. Proposed requirements for informed consent go beyond current federal regulations.
Hum Res Rep; 1994 Jul; 9(7):1-3. PubMed ID: 11659879
[No Abstract] [Full Text] [Related]
4. The concept of the IRB and bureaucratic reality: an exchange of letters.
van Eys J; Levine RJ
IRB; 1984; 6(4):8-10. PubMed ID: 11649563
[No Abstract] [Full Text] [Related]
5. Protection of human subjects.
United States
Code Fed Regul Shipping; 1982 Oct; Part 46, Sections 46.101 to 46.306():. PubMed ID: 11660819
[No Abstract] [Full Text] [Related]
6. Fears mount for gene scrutiny as watchdog faces axe.
Kiernan V
New Sci; 1996 Jun; 150(2033):10. PubMed ID: 11656540
[No Abstract] [Full Text] [Related]
7. The regulation of human experimentation in the United States--a personal odyssey.
Katz J
IRB; 1987; 9(1):1-6. PubMed ID: 11649890
[No Abstract] [Full Text] [Related]
8. Commission says institutional review boards should change procedures now.
Maloney DM
Hum Res Rep; 1999 Jan; 14(1):1-2. PubMed ID: 11657555
[No Abstract] [Full Text] [Related]
9. National commission proposes numerous new regulations of institutional review boards.
Maloney DM
Hum Res Rep; 1998 Oct; 13(10):1-2. PubMed ID: 11657739
[No Abstract] [Full Text] [Related]
10. The NIH trials of growth hormone for short stature.
Tauer CA
IRB; 1994 May; 16(3):1-9. PubMed ID: 11659923
[No Abstract] [Full Text] [Related]
11. Health Sciences Council of Japan adopts guidelines for gene therapy clinical research.
Int Dig Health Legis; 1995; 46(4):560-3. PubMed ID: 11657358
[No Abstract] [Full Text] [Related]
12. IRBs and pharmaceutical company funding of research.
Jellinek MS; Levine RJ
IRB; 1982 Oct; 4(8):9-10. PubMed ID: 11651693
[No Abstract] [Full Text] [Related]
13. Beyond localism: a proposal for a National Research Review Board.
Levine C; Caplan AL
IRB; 1986; 8(2):7-9. PubMed ID: 11649751
[No Abstract] [Full Text] [Related]
14. Guidelines for confidentiality in research on AIDS.
Bayer R; Levine C; Murray TH
IRB; 1984; 6(6):1-7. PubMed ID: 11649192
[No Abstract] [Full Text] [Related]
15. Protecting research subjects after consent: the case for the "research intermediary.
Reiser SJ; Knudson P
IRB; 1993; 15(2):10-1. PubMed ID: 11651567
[No Abstract] [Full Text] [Related]
16. Federal agency keeps review committee after public comments support continuation.
Maloney DM
Hum Res Rep; 1997 Jan; 12(1):1-2. PubMed ID: 11654603
[No Abstract] [Full Text] [Related]
17. Bill of rights for research subjects.
Prentice ED; Reitemeier PJ; Antonson DL; Kelso TK; Jameton A
IRB; 1993; 15(2):7-9. PubMed ID: 11651568
[No Abstract] [Full Text] [Related]
18. An introduction to NBAC's report on research involving persons with mental disorders that may affect decisionmaking capacity.
Childress JF
Account Res; 1999; 7(2-4):101-15. PubMed ID: 11658169
[No Abstract] [Full Text] [Related]
19. Consent to research with impaired human subjects: a trial policy for the intramural programs of the National Institutes of Health.
Fletcher JC; Dommel FW; Cowell DD
IRB; 1985; 7(6):1-6. PubMed ID: 11649686
[No Abstract] [Full Text] [Related]
20. Federal investigation concludes that institutional review boards are in trouble.
Maloney DM
Hum Res Rep; 1998 Aug; 13(8):1-2. PubMed ID: 11657190
[No Abstract] [Full Text] [Related]
[Next] [New Search]
